Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Fluid resuscitation in human sepsis: Time to rewrite history?

Byrne L, Van Haren F.

Ann Intensive Care. 2017 Dec;7(1):4. doi: 10.1186/s13613-016-0231-8. Review.

2.

Polymyxin B-immobilised haemoperfusion and mortality in critically ill patients with sepsis/septic shock: a protocol for a systematic review and meta-analysis.

Fujii T, Ganeko R, Kataoka Y, Featherstone R, Bagshaw SM, Furukawa TA.

BMJ Open. 2016 Nov 21;6(11):e012908. doi: 10.1136/bmjopen-2016-012908.

3.

Opening the Debate on the New Sepsis Definition Change Is Not Necessarily Progress: Revision of the Sepsis Definition Should Be Based on New Scientific Insights.

Cortés-Puch I, Hartog CS.

Am J Respir Crit Care Med. 2016 Jul 1;194(1):16-8. doi: 10.1164/rccm.201604-0734ED. No abstract available.

PMID:
27166972
4.

Combined Administration of Human Ghrelin and Human Growth Hormone Attenuates Organ Injury and Improves Survival in Aged Septic Rats.

Yang WL, Ma G, Zhou M, Aziz M, Yen HT, Mavropoulos S, Ojamaa K, Wang P.

Mol Med. 2016 Jan 25. doi: 10.2119/molmed.2015.00255. [Epub ahead of print]

5.

Poly (ADP-ribose) synthetase inhibitor has a heart protective effect in a rat model of experimental sepsis.

Zhang L, Yao J, Wang X, Li H, Liu T, Zhao W.

Int J Clin Exp Pathol. 2015 Sep 1;8(9):9824-35.

6.

Park7 interacts with p47(phox) to direct NADPH oxidase-dependent ROS production and protect against sepsis.

Liu W, Wu H, Chen L, Wen Y, Kong X, Gao WQ.

Cell Res. 2015 Jun;25(6):691-706. doi: 10.1038/cr.2015.63.

7.

Dexamethasone attenuates LPS-induced changes in expression of urea transporter and aquaporin proteins, ameliorating brain endotoxemia in mice.

Du Y, Meng Y, Lv X, Guo L, Wang X, Su Z, Li L, Li N, Zhao S, Zhao L, Zhao X.

Int J Clin Exp Pathol. 2014 Dec 1;7(12):8443-52.

8.

Immunosuppression after sepsis: systemic inflammation and sepsis induce a loss of naïve T-cells but no enduring cell-autonomous defects in T-cell function.

Markwart R, Condotta SA, Requardt RP, Borken F, Schubert K, Weigel C, Bauer M, Griffith TS, Förster M, Brunkhorst FM, Badovinac VP, Rubio I.

PLoS One. 2014 Dec 26;9(12):e115094. doi: 10.1371/journal.pone.0115094.

9.

Adenosine A1 receptor antagonist, L-97-1, improves survival and protects the kidney in a rat model of cecal ligation and puncture induced sepsis.

Wilson CN, Vance CO, Lechner MG, Matuschak GM, Lechner AJ.

Eur J Pharmacol. 2014 Oct 5;740:346-52. doi: 10.1016/j.ejphar.2014.07.012.

10.
11.

Metabolic theory of septic shock.

Pravda J.

World J Crit Care Med. 2014 May 4;3(2):45-54. doi: 10.5492/wjccm.v3.i2.45. Review.

12.

Biomarkers of early sepsis may be correlated with outcome.

Hong TH, Chang CH, Ko WJ, Lin CF, Liu HH, Chow LP, Huang CT, Yu SL, Chen YS.

J Transl Med. 2014 May 26;12:146. doi: 10.1186/1479-5876-12-146.

13.

Towards clinical applications of anti-endotoxin antibodies; a re-appraisal of the disconnect.

Hurley JC.

Toxins (Basel). 2013 Dec 18;5(12):2589-620. doi: 10.3390/toxins5122589. Review.

14.
15.

Anthracyclines induce DNA damage response-mediated protection against severe sepsis.

Figueiredo N, Chora A, Raquel H, Pejanovic N, Pereira P, Hartleben B, Neves-Costa A, Moita C, Pedroso D, Pinto A, Marques S, Faridi H, Costa P, Gozzelino R, Zhao JL, Soares MP, Gama-Carvalho M, Martinez J, Zhang Q, Döring G, Grompe M, Simas JP, Huber TB, Baltimore D, Gupta V, Green DR, Ferreira JA, Moita LF.

Immunity. 2013 Nov 14;39(5):874-84. doi: 10.1016/j.immuni.2013.08.039.

16.

B. anthracis associated cardiovascular dysfunction and shock: the potential contribution of both non-toxin and toxin components.

Remy KE, Qiu P, Li Y, Cui X, Eichacker PQ.

BMC Med. 2013 Oct 9;11:217. doi: 10.1186/1741-7015-11-217. Review.

17.

The epidemiology of acute organ system dysfunction from severe sepsis outside of the intensive care unit.

Rohde JM, Odden AJ, Bonham C, Kuhn L, Malani PN, Chen LM, Flanders SA, Iwashyna TJ.

J Hosp Med. 2013 May;8(5):243-7. doi: 10.1002/jhm.2012.

18.

Effect of parenteral selenium supplementation in critically ill patients: a systematic review and meta-analysis.

Huang TS, Shyu YC, Chen HY, Lin LM, Lo CY, Yuan SS, Chen PJ.

PLoS One. 2013;8(1):e54431. doi: 10.1371/journal.pone.0054431. Review.

19.
20.

Preclinical investigations reveal the broad-spectrum neutralizing activity of peptide Pep19-2.5 on bacterial pathogenicity factors.

Heinbockel L, Sánchez-Gómez S, Martinez de Tejada G, Dömming S, Brandenburg J, Kaconis Y, Hornef M, Dupont A, Marwitz S, Goldmann T, Ernst M, Gutsmann T, Schürholz T, Brandenburg K.

Antimicrob Agents Chemother. 2013 Mar;57(3):1480-7. doi: 10.1128/AAC.02066-12.

Items per page

Supplemental Content

Support Center